Halozyme Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.3M | 2.0M | 1.14 |
| 2025-06-30 | $3.6M | 3.6M | 0.99 |
| 2025-03-31 | $3.5M | 3.3M | 1.06 |
| 2024-09-30 | $1.4M | 1.4M | 1.00 |
| 2023-09-30 | $1.9M | 2.3M | 0.84 |
| 2023-06-30 | $5.7M | 6.8M | 0.83 |
| 2023-03-31 | $7.7M | 9.1M | 0.85 |
| 2022-12-31 | $12M | 13M | 0.97 |
| 2022-09-30 | $7.3M | 8.6M | 0.85 |
| 2022-06-30 | $7.4M | 8.4M | 0.88 |
| 2022-03-31 | $12M | 14M | 0.87 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft